Results 1 to 10 of about 1,759 (167)

Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder [PDF]

open access: greenNature Communications
Isolated rapid eye movement sleep behavior disorder is a prodrome of α-synucleinopathies. Using positron emission tomography, we assessed changes in Parkinson’s disease-related motor and cognitive metabolic networks and caudate/putamen dopaminergic input
Chris C. Tang   +13 more
doaj   +7 more sources

Predicting Phenoconversion in Isolated RBD: Machine Learning and Explainable AI Approach [PDF]

open access: goldClocks & Sleep
Isolated rapid eye movement (REM) sleep behavior disorder (iRBD) is recognized as a precursor to neurodegenerative diseases. This study aimed to develop predictive models for the timing and subtype of phenoconversion in iRBD.
Yong-Woo Shin   +6 more
doaj   +5 more sources

The impact of CYP2C19 genotype on phenoconversion by concomitant medication [PDF]

open access: goldFrontiers in Pharmacology, 2023
Introduction: Pharmacogenetics-informed drug prescribing is increasingly applied in clinical practice. Typically, drug metabolizing phenotypes are determined based on genetic test results, whereupon dosage or drugs are adjusted.
Laura M. de Jong   +11 more
doaj   +7 more sources

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study [PDF]

open access: goldClinical and Translational Science
Phenoconversion is the discrepancy between genotype‐predicted phenotype and clinical phenotype, due to nongenetic factors. In oncology patients, the impact of phenoconversion on drug selection, efficacy, toxicity, and treatment outcomes is unknown.
Rachel Conyers   +13 more
doaj   +3 more sources

Factors associated with phenoconversion of idiopathic rapid eye movement sleep behavior disorder: a prospective study [PDF]

open access: goldnpj Parkinson's Disease
This study explores the effect of risk factors on the progression of idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) to α-synucleinopathies in a Chinese cohort.
Yuan Yuan   +9 more
doaj   +3 more sources

CD4+ T-cell transcription factors predict phenoconversion in idiopathic rapid eye movement sleep behavior disorder [PDF]

open access: goldFuture Science OA
Aim: Early biomarkers of phenoconversion to neurodegeneration are crucial to identify individuals at high risk. In patients with idiopathic REM sleep behavior disorder (iRBD), the strongest risk factor for neurodegeneration, CD4+ T cells exhibit a ...
Monica Pinoli   +5 more
doaj   +3 more sources

Machine Learning Predicts Phenoconversion from Polysomnography in Isolated REM Sleep Behavior Disorder [PDF]

open access: goldBrain Sciences
Isolated rapid eye movement (REM) sleep behavior disorder (iRBD) is a prodromal stage of alpha-synucleinopathies. This study aimed at developing a fully-automated machine learning framework for the prediction of phenoconversion in patients with iRBD by ...
Matteo Cesari   +9 more
doaj   +3 more sources

Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderResearch in context [PDF]

open access: goldEBioMedicine
Summary: Background: Synucleinopathies include a spectrum of disorders varying in features and severity, including idiopathic/isolated REM sleep behaviour disorder (iRBD), Parkinson's disease (PD), and dementia with Lewy bodies (DLB).
Stephen Joza   +86 more
doaj   +3 more sources

CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling. [PDF]

open access: goldPLoS ONE, 2016
Benign prostate hyperplasia (BPH), an enlargement of the prostate common in aging in men, is associated with urinary voiding dysfunction manifest as Lower Urinary Tract Symptoms (LUTS).
José A Rodríguez-Nieves   +4 more
doaj   +3 more sources

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting [PDF]

open access: goldFrontiers in Psychiatry, 2021
Introduction: Polypharmacy and genetic variants that strongly influence medication response (pharmacogenomics, PGx) are two well-described risk factors for adverse drug reactions.
Sam Mostafa   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy